Finite Element Structural Analysis of a Pit Viper 235 Main Frame

Autor: Dr. Anand Sn, Dr. Manohar Hs, Kumar Thanaiah

Publikováno v: Journal of scholastic Engineering Science and Management
Journal of scholastic Engineering Science and Management, Jsesm, 2021, 1 (3), pp.19-31

The Pit Viper series 235 (PV-235) blast hole drill offers new technological innovations for many applications including hard rock mining for metals and overburden coal mining. This paper is centered on an ongoing structural analysis of PV-235 Mainfra

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a60d8d7787ecd730bd140b543fbb943
https://hal.archives-ouvertes.fr/hal-03284127/document

Creating a Modified Version of the Cambridge Multimorbidity Score to Predict Mortality in People Older Than 16 Years: Model Development and Validation.

Autor: Kar D; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.; Peninsula Medical School, University of Plymouth, Plymouth, United Kingdom., Taylor KS; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom., Joy M; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom., Venkatesan S; Medical & Payer Evidence Statistics, BioPharmaceuticals Medical, AstraZeneca PLC, Cambridge, United Kingdom., Meeraus W; Medical Evidence, Vaccines and Immune Therapies, AstraZeneca PLC, Cambridge, United Kingdom., Taylor S; Medical Evidence, Vaccines and Immune Therapies, AstraZeneca PLC, Cambridge, United Kingdom., Anand SN; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom., Ferreira F; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom., Jamie G; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom., Fan X; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom., de Lusignan S; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.; Royal College of General Practitioners of the United Kingdom, London, United Kingdom.

Publikováno v: Journal of medical Internet research [J Med Internet Res] 2024 Aug 26; Vol. 26, pp. e56042. Date of Electronic Publication: 2024 Aug 26.

AZD1222 effectiveness against severe COVID-19 in individuals with comorbidity or frailty: The RAVEN cohort study.

Autor: Meeraus W; Medical Evidence, Vaccines & Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK., Joy M; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Ouwens M; Medical & Payer Evidence Statistics, BioPharmaceuticals Medical, AstraZeneca, Mölndal, Sweden., Taylor KS; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Venkatesan S; Medical & Payer Evidence Statistics, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK., Dennis J; Momentum Data, St Albans, UK., Tran TN; Biopharmaceutical Medicine Respiratory and Immunology, AstraZeneca, Gaithersburg, MD, USA., Dashtban A; Institute of Health Informatics, University College London, London, UK., Fan X; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Williams R; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Morris T; Medical and Scientific Affairs, BioPharmaceuticals Medical, AstraZeneca, London, UK., Carty L; Medical & Payer Evidence Statistics, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK., Kar D; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Hoang U; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Feher M; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Forbes A; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Jamie G; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Hinton W; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Sanecka K; Medical Evidence, Vaccines & Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, Warsaw, Poland., Byford R; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Anand SN; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Hobbs FDR; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Clifton DA; Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Oxford, UK., Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK., Taylor S; Medical Evidence, Vaccines & Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK., de Lusignan S; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK; Royal College of General Practitioners Research and Surveillance Centre, London, UK. Electronic address: simon.delusignan@phc.ox.ac.uk.

Publikováno v: The Journal of infection [J Infect] 2024 Apr; Vol. 88 (4), pp. 106129. Date of Electronic Publication: 2024 Feb 29.

Uptake of COVID-19 vaccinations amongst 3,433,483 children and young people: meta-analysis of UK prospective cohorts.

Autor: Aldridge SJ; Population Data Science, Swansea University Medical School, Faculty of Medicine, Health, and Life Science, Swansea University, Swansea, UK. s.j.aldridge@swansea.ac.uk., Agrawal U; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Murphy S; Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queen's University, Belfast, UK., Millington T; Usher Institute, University of Edinburgh, Edinburgh, UK., Akbari A; Population Data Science, Swansea University Medical School, Faculty of Medicine, Health, and Life Science, Swansea University, Swansea, UK., Almaghrabi F; Usher Institute, University of Edinburgh, Edinburgh, UK., Anand SN; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Bedston S; Population Data Science, Swansea University Medical School, Faculty of Medicine, Health, and Life Science, Swansea University, Swansea, UK., Goudie R; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Griffiths R; Population Data Science, Swansea University Medical School, Faculty of Medicine, Health, and Life Science, Swansea University, Swansea, UK., Joy M; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Lowthian E; Department of Education and Childhood Studies, School of Social Sciences, Swansea University, Swansea, UK., de Lusignan S; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Patterson L; Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queen's University, Belfast, UK.; Public Health Agency, Belfast, UK., Robertson C; Department of Mathematics and Statistics, Strathclyde University, Glasgow, UK and Public Health Scotland, Glasgow, UK., Rudan I; Centre for Global Health, Usher Institute, the University of Edinburgh, Edinburgh, UK., Bradley DT; Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queen's University, Belfast, UK.; Public Health Agency, Belfast, UK., Lyons RA; Population Data Science, Swansea University Medical School, Faculty of Medicine, Health, and Life Science, Swansea University, Swansea, UK., Sheikh A; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Owen RK; Population Data Science, Swansea University Medical School, Faculty of Medicine, Health, and Life Science, Swansea University, Swansea, UK. r.k.owen@swansea.ac.uk.

Publikováno v: Nature communications [Nat Commun] 2024 Mar 15; Vol. 15 (1), pp. 2363. Date of Electronic Publication: 2024 Mar 15.

Thrombocytopenic, thromboembolic and haemorrhagic events following second dose with BNT162b2 and ChAdOx1: self-controlled case series analysis of the English national sentinel cohort.

Autor: Joy M; Nuffield Department of Primary Care Health Sciences, University of Oxford, UK., Agrawal U; Nuffield Department of Primary Care Health Sciences, University of Oxford, UK., Fan X; Nuffield Department of Primary Care Health Sciences, University of Oxford, UK., Robertson C; Department of Mathematics and Statistics, University of Strathclyde, Glasgow, UK.; Public Health Scotland, Glasgow, UK., Anand SN; Nuffield Department of Primary Care Health Sciences, University of Oxford, UK., Ordonez-Mena J; Nuffield Department of Primary Care Health Sciences, University of Oxford, UK., Byford R; Nuffield Department of Primary Care Health Sciences, University of Oxford, UK., Goudie R; Nuffield Department of Primary Care Health Sciences, University of Oxford, UK., Jamie G; Nuffield Department of Primary Care Health Sciences, University of Oxford, UK., Kar D; Nuffield Department of Primary Care Health Sciences, University of Oxford, UK., Williams J; Nuffield Department of Primary Care Health Sciences, University of Oxford, UK., Marsden GL; Royal College of General Practitioners, London, UK., Tzortziou-Brown V; Royal College of General Practitioners, London, UK., Sheikh SA; Usher Institute, The University of Edinburgh, Edinburgh, UK., Hobbs FDR; Nuffield Department of Primary Care Health Sciences, University of Oxford, UK., de Lusignan S; Nuffield Department of Primary Care Health Sciences, University of Oxford, UK.

Publikováno v: The Lancet regional health. Europe [Lancet Reg Health Eur] 2023 Jul 18; Vol. 32, pp. 100681. Date of Electronic Publication: 2023 Jul 18 (Print Publication: 2023).